Amalgamated Bank Increases Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Amalgamated Bank lifted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 136.4% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 104,914 shares of the medical instruments supplier’s stock after purchasing an additional 60,534 shares during the period. Amalgamated Bank owned about 0.05% of DENTSPLY SIRONA worth $2,613,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Principal Securities Inc. purchased a new stake in shares of DENTSPLY SIRONA in the 4th quarter worth approximately $26,000. LRI Investments LLC raised its stake in shares of DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after acquiring an additional 564 shares in the last quarter. Rothschild Investment LLC acquired a new position in DENTSPLY SIRONA during the 2nd quarter valued at approximately $32,000. Central Pacific Bank Trust Division acquired a new position in DENTSPLY SIRONA during the 1st quarter valued at approximately $64,000. Finally, Mather Group LLC. acquired a new position in DENTSPLY SIRONA during the 1st quarter valued at approximately $72,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY opened at $26.09 on Wednesday. The company’s fifty day moving average price is $25.56 and its 200 day moving average price is $27.72. DENTSPLY SIRONA Inc. has a 1 year low of $23.58 and a 1 year high of $37.60. The company has a market capitalization of $5.42 billion, a PE ratio of -59.30, a price-to-earnings-growth ratio of 1.25 and a beta of 1.00. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The firm had revenue of $984.00 million for the quarter, compared to analysts’ expectations of $993.61 million. During the same period last year, the company posted $0.51 earnings per share. The business’s quarterly revenue was down 4.3% on a year-over-year basis. On average, research analysts predict that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 2.45%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s payout ratio is -145.45%.

Analyst Ratings Changes

XRAY has been the topic of a number of recent analyst reports. Needham & Company LLC restated a “buy” rating and set a $34.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Barrington Research restated an “outperform” rating and set a $36.00 price target on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Stifel Nicolaus cut their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a research note on Thursday, July 18th. Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating on the stock in a research note on Monday, July 22nd. Finally, Evercore ISI dropped their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, July 9th. Five research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $33.22.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.